These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 16969361

  • 1. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS, Kazemi F, Najafian A, Mohammady M, Aminorroaya A, Amini M.
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [Abstract] [Full Text] [Related]

  • 2. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS.
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec 01; 123(2):204-11. PubMed ID: 16316811
    [Abstract] [Full Text] [Related]

  • 4. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
    Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH.
    Hum Reprod; 2006 Jan 01; 21(1):80-9. PubMed ID: 16199429
    [Abstract] [Full Text] [Related]

  • 5. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.
    J Am Acad Nurse Pract; 2007 Jul 01; 19(7):368-77. PubMed ID: 17680902
    [Abstract] [Full Text] [Related]

  • 6. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Herrmann BL, Saller B, Stratmann M, Berg C, Mann K, Janssen OE.
    Horm Metab Res; 2005 Jan 01; 37(1):49-52. PubMed ID: 15702440
    [Abstract] [Full Text] [Related]

  • 7. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G.
    Clin Ther; 2008 Jun 01; 30(6):1168-76. PubMed ID: 18640473
    [Abstract] [Full Text] [Related]

  • 8. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ.
    Pharmacotherapy; 2009 Jun 01; 29(6):725-35. PubMed ID: 19476423
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, Sitagliptin Study 035 Group.
    Diabetes Obes Metab; 2007 Sep 01; 9(5):733-45. PubMed ID: 17593236
    [Abstract] [Full Text] [Related]

  • 10. Role of metformin for weight management in patients without type 2 diabetes.
    Desilets AR, Dhakal-Karki S, Dunican KC.
    Ann Pharmacother; 2008 Jun 01; 42(6):817-26. PubMed ID: 18477733
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients.
    Kaya A, Aydin N, Topsever P, Filiz M, Oztürk A, Dağar A, Kilinç E, Ekmekcioglu C.
    Biomed Pharmacother; 2004 Dec 01; 58(10):582-7. PubMed ID: 15589067
    [Abstract] [Full Text] [Related]

  • 12. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
    Garrison R, Chambliss WG.
    Altern Ther Health Med; 2006 Dec 01; 12(1):50-4. PubMed ID: 16454147
    [Abstract] [Full Text] [Related]

  • 13. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
    Andreadis EA, Katsanou PM, Georgiopoulos DX, Tsourous GI, Yfanti GK, Gouveri ET, Diamantopoulos EJ.
    Exp Clin Endocrinol Diabetes; 2009 Apr 01; 117(4):175-80. PubMed ID: 19053032
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G.
    Am J Gastroenterol; 2005 May 01; 100(5):1082-90. PubMed ID: 15842582
    [Abstract] [Full Text] [Related]

  • 15. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A, Caumo A, Graci S, Castagna G, Viberti G, Liuzzi A.
    Diabetes Obes Metab; 2008 Jun 01; 10(6):460-7. PubMed ID: 17394563
    [Abstract] [Full Text] [Related]

  • 16. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being.
    Moon RJ, Bascombe LA, Holt RI.
    Diabetes Obes Metab; 2007 Jan 01; 9(1):143-5. PubMed ID: 17199734
    [Abstract] [Full Text] [Related]

  • 17. [Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome].
    Pekhlivanov B, Mitkov M, Kavŭrdzhikova S.
    Akush Ginekol (Sofiia); 2006 Jan 01; 45(6):29-35. PubMed ID: 17168480
    [Abstract] [Full Text] [Related]

  • 18. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.
    Faramarzi M, Alipor A, Esmaelzadeh S, Kheirkhah F, Poladi K, Pash H.
    J Affect Disord; 2008 May 01; 108(1-2):159-64. PubMed ID: 17936366
    [Abstract] [Full Text] [Related]

  • 19. Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery.
    Dolfing JG, Wolffenbuttel BH, ten Hoor-Aukema NM, Schweitzer DH.
    Obes Surg; 2005 Sep 01; 15(8):1185-91. PubMed ID: 16197794
    [Abstract] [Full Text] [Related]

  • 20. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
    Devlin MJ, Goldfein JA, Petkova E, Jiang H, Raizman PS, Wolk S, Mayer L, Carino J, Bellace D, Kamenetz C, Dobrow I, Walsh BT.
    Obes Res; 2005 Jun 01; 13(6):1077-88. PubMed ID: 15976151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.